American Society of Nephrology (ASN) Kidney Week 2023 C3G

American Society of Nephrology (ASN) Kidney Week 2023

Phase 3, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Treatment of C3G or IC-MPGN

Access Resources

Efficacy and safety of 12-week pegcetacoplan in kidney transplant recipients with recurrent C3G or primary IC-MPGN: 12-week results from the NOBLE study

Access Resources

Back to Conference Resources

IG-MPGN and C3G Congress Presentations

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.

American Society of Nephrology (ASN) Kidney Week 2023

Back to Conference Resources

Report an Adverse Event or Product complaint

Ask a Medical Question

Connect with an MSL

Landing